Most patients experienced at least 10 symptoms and at least one aspect of emotional impact, such as worry, depression, or anxiety.

Researchers studied the relationship between lymphovascular invasion and adverse outcomes in patients with cutaneous squamous cell carcinoma.

Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as p ...

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Whiteboards were adapted to ambulatory care areas as a communication tool similar to their use in the inpatient setting.

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

Researchers sought to determine the social return on investment of a support program consisting of dedicated prostate cancer specialized nurses in Australia.

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

Postoperative complication rates after mastectomy are higher in older women, but with careful selection and assessment, they may still be a candidate for immediate breast reconstruction.